-
公开(公告)号:EP4431092A1
公开(公告)日:2024-09-18
申请号:EP23162142.6
申请日:2023-03-15
申请人: Dr. Schär S.P.A.
摘要: Embodiments of the present disclosure relate to the field of therapeutic treatment of diseases mediate by immune and inflammatory components, in particular Rheumatoid arthritis (RA) and more particularly, to the use of medium chain triglycerides (MCT) and optionally dietary fibers, for use in the therapeutic treatment of said diseases, in particular RA.